March 26, 2022 Comments Off on New patent for Strongbridge drug RECORLEV Posted in: Patent Added Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are five patents protecting this drug. This drug has twenty-seven…
The post New patent for Strongbridge drug RECORLEV appeared fir…
March 26, 2022 Comments Off on New patent for Deciphera Pharms drug QINLOCK Posted in: Patent Added Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on Dr…
